SEC Form 3 · accession 0001753763-18-000001
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John K Scott Jr.
10% Owner
Period of report
Sep 13, 2018
Accepted (ET)
Sep 24, 2018 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 21,904,422 | D | ||
| Common Stock | holding | — | — | — | 52,785 | I | By Spouse | |
| Common StockF1 | holding | — | — | — | 50,000 | I | By Daughter | |
| Common StockF1 | holding | — | — | — | 50,000 | I | By Son | |
| Common StockF1 | holding | — | — | — | 50,000 | I | By Son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.